BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: McDonnel AC, Van Kirk EA, Isaak DD, Murdoch WJ. Inhibitory effects of progesterone on plasma membrane fluidity and tumorigenic potential of ovarian epithelial cancer cells. Exp Biol Med (Maywood) 2003;228:308-14. [PMID: 12626776 DOI: 10.1177/153537020322800310] [Cited by in Crossref: 25] [Cited by in F6Publishing: 25] [Article Influence: 1.3] [Reference Citation Analysis]
Number Citing Articles
1 Björkgren I, Mendoza S, Chung DH, Haoui M, Petersen NT, Lishko PV. The epithelial potassium channel Kir7.1 is stimulated by progesterone. J Gen Physiol 2021;153:e202112924. [PMID: 34387656 DOI: 10.1085/jgp.202112924] [Reference Citation Analysis]
2 Han GH, Hwang I, Cho H, Ylaya K, Choi JA, Kwon H, Chung JY, Hewitt SM, Kim JH. Clinical Significance of Tumor Infiltrating Lymphocytes in Association with Hormone Receptor Expression Patterns in Epithelial Ovarian Cancer. Int J Mol Sci 2021;22:5714. [PMID: 34071938 DOI: 10.3390/ijms22115714] [Reference Citation Analysis]
3 Ji R, Li Y, He C, Zhu X, He A, Lu Y. Detection and analysis of multiple biomarkers in ovarian cancer: clinical significance in diagnosis, treatment, and prognosis evaluation. Gland Surg 2020;9:2175-86. [PMID: 33447568 DOI: 10.21037/gs-20-811] [Reference Citation Analysis]
4 Ayyagari VN, Wang X, Diaz-Sylvester PL, Groesch K, Brard L. Assessment of acyl-CoA cholesterol acyltransferase (ACAT-1) role in ovarian cancer progression-An in vitro study. PLoS One 2020;15:e0228024. [PMID: 31978092 DOI: 10.1371/journal.pone.0228024] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 5.0] [Reference Citation Analysis]
5 Pelegrina LT, de Los Ángeles Sanhueza M, Ramona Cáceres AR, Cuello-Carrión D, Rodriguez CE, Laconi MR. Effect of progesterone and first evidence about allopregnanolone action on the progression of epithelial human ovarian cancer cell lines. J Steroid Biochem Mol Biol 2020;196:105492. [PMID: 31614205 DOI: 10.1016/j.jsbmb.2019.105492] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
6 Pampalakis G, Politi AL, Papanastasiou A, Sotiropoulou G. Distinct cholesterogenic and lipidogenic gene expression patterns in ovarian cancer - a new pool of biomarkers. Genes Cancer 2015;6:472-9. [PMID: 26807200 DOI: 10.18632/genesandcancer.87] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.2] [Reference Citation Analysis]
7 Jönsson JM, Arildsen NS, Malander S, Måsbäck A, Hartman L, Nilbert M, Hedenfalk I. Sex Steroid Hormone Receptor Expression Affects Ovarian Cancer Survival. Transl Oncol 2015;8:424-33. [PMID: 26500033 DOI: 10.1016/j.tranon.2015.09.002] [Cited by in Crossref: 22] [Cited by in F6Publishing: 24] [Article Influence: 3.1] [Reference Citation Analysis]
8 Zhang P, Wang C, Cheng L, Zhang P, Guo L, Liu W, Zhang Z, Huang Y, Ou Q, Wen X, Tian Y. Development of a multi-marker model combining HE4, CA125, progesterone, and estradiol for distinguishing benign from malignant pelvic masses in postmenopausal women. Tumor Biol 2016;37:2183-91. [DOI: 10.1007/s13277-015-4037-3] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
9 Han KH, Kim MK, Kim HS, Chung HH, Song YS. Protective Effect of Progesterone during Pregnancy against Ovarian Cancer. J Cancer Prev 2013;18:113-22. [PMID: 25337537 DOI: 10.15430/jcp.2013.18.2.113] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 0.6] [Reference Citation Analysis]
10 Ajdžanović V, Mojić M, Maksimović-ivanić D, Bulatović M, Mijatović S, Milošević V, Spasojević I. Membrane Fluidity, Invasiveness and Dynamic Phenotype of Metastatic Prostate Cancer Cells after Treatment with Soy Isoflavones. J Membrane Biol 2013;246:307-14. [DOI: 10.1007/s00232-013-9531-1] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 1.4] [Reference Citation Analysis]
11 Wang L, Che X, Li X, Lv J, Zhou C, Wang S, Zhu Z, Wang L, Lin G, Lu R, Yao Z. Tyroservatide therapy for tumor invasion and metastasis of human ovarian carcinoma and colon carcinoma. Anti-Cancer Drugs 2012;23:1067-77. [DOI: 10.1097/cad.0b013e328357bd31] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
12 Sinn BV, Darb-Esfahani S, Wirtz RM, Budczies J, Sehouli J, Chekerov R, Dietel M, Denkert C. Evaluation of a hormone receptor-positive ovarian carcinoma subtype with a favourable prognosis by determination of progesterone receptor and oestrogen receptor 1 mRNA expression in formalin-fixed paraffin-embedded tissue. Histopathology 2011;59:918-27. [PMID: 22092403 DOI: 10.1111/j.1365-2559.2011.04028.x] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 1.6] [Reference Citation Analysis]
13 Hess D, Chisholm JW, Igal RA. Inhibition of stearoylCoA desaturase activity blocks cell cycle progression and induces programmed cell death in lung cancer cells. PLoS One. 2010;5:e11394. [PMID: 20613975 DOI: 10.1371/journal.pone.0011394] [Cited by in Crossref: 110] [Cited by in F6Publishing: 111] [Article Influence: 9.2] [Reference Citation Analysis]
14 Ishikawa H, Ishi K, Serna VA, Kakazu R, Bulun SE, Kurita T. Progesterone is essential for maintenance and growth of uterine leiomyoma. Endocrinology 2010;151:2433-42. [PMID: 20375184 DOI: 10.1210/en.2009-1225] [Cited by in Crossref: 199] [Cited by in F6Publishing: 181] [Article Influence: 16.6] [Reference Citation Analysis]
15 Peluso JJ, Gawkowska A, Liu X, Shioda T, Pru JK. Progesterone receptor membrane component-1 regulates the development and Cisplatin sensitivity of human ovarian tumors in athymic nude mice. Endocrinology 2009;150:4846-54. [PMID: 19797399 DOI: 10.1210/en.2009-0730] [Cited by in Crossref: 37] [Cited by in F6Publishing: 37] [Article Influence: 2.8] [Reference Citation Analysis]
16 Armaiz-Pena GN, Mangala LS, Spannuth WA, Lin YG, Jennings NB, Nick AM, Langley RR, Schmandt R, Lutgendorf SK, Cole SW, Sood AK. Estrous cycle modulates ovarian carcinoma growth. Clin Cancer Res 2009;15:2971-8. [PMID: 19383821 DOI: 10.1158/1078-0432.CCR-08-2525] [Cited by in Crossref: 25] [Cited by in F6Publishing: 22] [Article Influence: 1.9] [Reference Citation Analysis]
17 Murdoch WJ, Van Kirk EA, Isaak DD, Shen Y. Progesterone facilitates cisplatin toxicity in epithelial ovarian cancer cells and xenografts. Gynecol Oncol 2008;110:251-5. [PMID: 18495224 DOI: 10.1016/j.ygyno.2008.03.021] [Cited by in Crossref: 15] [Cited by in F6Publishing: 17] [Article Influence: 1.1] [Reference Citation Analysis]
18 Wilcox CB, Feddes GO, Willett-Brozick JE, Hsu LC, DeLoia JA, Baysal BE. Coordinate up-regulation of TMEM97 and cholesterol biosynthesis genes in normal ovarian surface epithelial cells treated with progesterone: implications for pathogenesis of ovarian cancer. BMC Cancer 2007;7:223. [PMID: 18070364 DOI: 10.1186/1471-2407-7-223] [Cited by in Crossref: 32] [Cited by in F6Publishing: 30] [Article Influence: 2.1] [Reference Citation Analysis]
19 Alexander BM, Van Kirk EA, Naughton LM, Murdoch WJ. Ovarian morphometrics in TP53-deficient mice. Anat Rec (Hoboken) 2007;290:59-64. [PMID: 17441198 DOI: 10.1002/ar.20409] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.3] [Reference Citation Analysis]
20 Zheng H, Kavanagh JJ, Hu W, Liao Q, Fu S. Hormonal therapy in ovarian cancer. Int J Gynecol Cancer. 2007;17:325-338. [PMID: 17362310 DOI: 10.1111/j.1525-1438.2006.00749.x] [Cited by in Crossref: 31] [Cited by in F6Publishing: 29] [Article Influence: 2.1] [Reference Citation Analysis]
21 Leung PC, Choi JH. Endocrine signaling in ovarian surface epithelium and cancer. Hum Reprod Update 2007;13:143-62. [PMID: 17071638 DOI: 10.1093/humupd/dml002] [Cited by in Crossref: 52] [Cited by in F6Publishing: 53] [Article Influence: 3.3] [Reference Citation Analysis]
22 Chao KC, Wang PH, Yen MS, Chang CC, Chi CW. Role of estrogen and progesterone in the survival of ovarian tumors--a study of the human ovarian adenocarcinoma cell line OC-117-VGH. J Chin Med Assoc 2005;68:360-7. [PMID: 16138714 DOI: 10.1016/S1726-4901(09)70176-5] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
23 Mcdonnel AC, Van Kirk EA, Isaak DD, Murdoch WJ. Effects of progesterone on ovarian tumorigenesis in xenografted mice. Cancer Letters 2005;221:49-53. [DOI: 10.1016/j.canlet.2004.09.011] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 0.8] [Reference Citation Analysis]
24 Blumenthal M, Kardosh A, Dubeau L, Borok Z, Schönthal AH. Suppression of the transformed phenotype and induction of differentiation-like characteristics in cultured ovarian tumor cells by chronic treatment with progesterone: REVERSION BY PROGESTERONE. Mol Carcinog 2003;38:160-9. [DOI: 10.1002/mc.10155] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.3] [Reference Citation Analysis]
25 Ho SM. Estrogen, progesterone and epithelial ovarian cancer. Reprod Biol Endocrinol 2003;1:73. [PMID: 14577831 DOI: 10.1186/1477-7827-1-73] [Cited by in Crossref: 161] [Cited by in F6Publishing: 146] [Article Influence: 8.5] [Reference Citation Analysis]